|
EU Risk Management Guidance May Aid U.S., Global Risk Management Plans
Drugmakers developing risk management plans for the EU should synchronize them as much as possible with RMP requirements in the U.S. and elsewhere to facilitate broader acceptance, experts say.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives